Sugiyama Y - Search Results

1

Effect of aminoguanidine on lipopolysaccharide-induced changes in rat liver transporters and transcription factors.

Aoki K, Nakajima M, Hoshi Y, Saso N, Kato S, Sugiyama Y, Sato H. Aoki K, et al. Among authors: sugiyama y. Biol Pharm Bull. 2008 Mar;31(3):412-20. doi: 10.1248/bpb.31.412. Biol Pharm Bull. 2008. PMID: 18310902 Free article.

2

Nitric oxide and peroxynitrite regulate transporter transcription in rat liver slices.

Aoki K, Saso N, Kato S, Sugiyama Y, Sato H. Aoki K, et al. Among authors: sugiyama y. Biol Pharm Bull. 2008 Oct;31(10):1882-7. doi: 10.1248/bpb.31.1882. Biol Pharm Bull. 2008. PMID: 18827348 Free article.

3

In vitro and in vivo correlation of the inhibitory effect of cyclosporin A on the transporter-mediated hepatic uptake of cerivastatin in rats.

Shitara Y, Hirano M, Adachi Y, Itoh T, Sato H, Sugiyama Y. Shitara Y, et al. Among authors: sugiyama y. Drug Metab Dispos. 2004 Dec;32(12):1468-75. doi: 10.1124/dmd.32.12.. Drug Metab Dispos. 2004. PMID: 15550721

4

Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs.

Shitara Y, Sato H, Sugiyama Y. Shitara Y, et al. Among authors: sugiyama y. Annu Rev Pharmacol Toxicol. 2005;45:689-723. doi: 10.1146/annurev.pharmtox.44.101802.121444. Annu Rev Pharmacol Toxicol. 2005. PMID: 15822193 Review.

5

Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A.

Shitara Y, Itoh T, Sato H, Li AP, Sugiyama Y. Shitara Y, et al. Among authors: sugiyama y. J Pharmacol Exp Ther. 2003 Feb;304(2):610-6. doi: 10.1124/jpet.102.041921. J Pharmacol Exp Ther. 2003. PMID: 12538813

6

Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil.

Shitara Y, Hirano M, Sato H, Sugiyama Y. Shitara Y, et al. Among authors: sugiyama y. J Pharmacol Exp Ther. 2004 Oct;311(1):228-36. doi: 10.1124/jpet.104.068536. Epub 2004 Jun 11. J Pharmacol Exp Ther. 2004. PMID: 15194707

7

The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling.

Kato M, Shitara Y, Sato H, Yoshisue K, Hirano M, Ikeda T, Sugiyama Y. Kato M, et al. Among authors: sugiyama y. Pharm Res. 2008 Aug;25(8):1891-901. doi: 10.1007/s11095-008-9607-2. Epub 2008 May 16. Pharm Res. 2008. PMID: 18483837

8

Expression and regulation of breast cancer resistance protein and multidrug resistance associated protein 2 in BALB/c mice.

Han Y, Sugiyama Y. Han Y, et al. Among authors: sugiyama y. Biol Pharm Bull. 2006 May;29(5):1032-5. doi: 10.1248/bpb.29.1032. Biol Pharm Bull. 2006. PMID: 16651740 Free article.

9

Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport.

Ito K, Suzuki H, Horie T, Sugiyama Y. Ito K, et al. Among authors: sugiyama y. Pharm Res. 2005 Oct;22(10):1559-77. doi: 10.1007/s11095-005-6810-2. Epub 2005 Sep 22. Pharm Res. 2005. PMID: 16180115 Review.

10

Characterization of the enhancing effect of protamine on the proliferative activity of hepatocyte growth factor in rat hepatocytes.

Liu KX, Kato Y, Matsumoto K, Nakamura T, Kaku T, Sugiyama Y. Liu KX, et al. Among authors: sugiyama y. Pharm Res. 2009 Apr;26(4):1012-21. doi: 10.1007/s11095-008-9810-1. Epub 2009 Jan 6. Pharm Res. 2009. PMID: 19127344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,702 results

Search Page

Filters